{"schema_version":"secwatch.filing_event.v1","accession":"0000849146-24-000122","form_type":"8-K","ticker":"LFVN","cik":"0000849146","company_name":"Lifevantage Corp","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.147297+00:00","generated_at":"2026-05-30T09:31:05.671342+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"LifeVantage Q1 revenue falls 8.1% to $47.2M; net income rises to $0.14 diluted EPS","bullets":["Net income of $0.14 diluted EPS vs $0.05 a year ago; adjusted EPS $0.15 vs $0.13.","Americas revenue down 4.2%; Asia/Pacific & Europe down 19.7% (18.7% constant currency).","Adjusted EBITDA rose 11% to $4.4M from $4.0M; margin improved 160 bps.","FY2025 guidance reaffirmed: revenue $200M-$210M, adj. EBITDA $18M-$21M, adj. EPS $0.70-$0.80.","Declared $0.04 dividend payable Dec 16, record Dec 2; repurchased 0.1M shares for $1.1M."],"urls":{"canonical":"https://secwatch.observer/filing/0000849146-24-000122","json":"https://secwatch.observer/filing/0000849146-24-000122.json","markdown":"https://secwatch.observer/filing/0000849146-24-000122.md","text":"https://secwatch.observer/filing/0000849146-24-000122.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849146/000084914624000122/0000849146-24-000122-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849146/000084914624000122/lfvn-20241029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:31:05.671342+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}